logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Surya Kanta De

This inventor holds 12 USPTO granted patents and 4 published patent applications. Top assignees: Collidion, Inc., Plex Pharmaceuticals, Inc., Burnham Institute for Medical Research. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Surya Kanta De. Retrieved from https://idiyas.com/inventor/surya-kanta-de

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal8 out of 9 
 
Collidion, Inc.
 patents
silverMedal2 out of 2 
 
Plex Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 55 
 
Burnham Institute for Medical Research
 patents
4. 1 out of 2 
 
Calasia Pharmaceuticals, Inc.
 patents

Years Active: 2011-2025

Loading Chart...
12 patents (USPTO):Explore Patents
1. 12402628 - Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating (2025-09-02),
2. 12371406 - Dual acting FKBP12 and FKBP52 inhibitors (2025-07-29),
3. 12065407 - Dual acting FKBP12 and FKBP52 inhibitors (2024-08-20),
4. 12048307 - Compositions, methods and uses for cleaning, disinfecting and/or sterilizing (2024-07-30),
5. 11974573 - Compositions, methods and uses for cleaning, disinfecting and/or sterilizing (2024-05-07),
6. 11910797 - Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating (2024-02-27),
7. 11872236 - Pharmacological agents for treating ocular diseases (2024-01-16),
8. 11272710 - Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating (2022-03-15),
9. 10750748 - Compositions, methods and uses for cleaning, disinfecting and/or sterilizing (2020-08-25),
10. 10750747 - Compositions, methods and uses for cleaning, disinfecting and/or sterilizing (2020-08-25),
11. 10412968 - Compositions, methods and uses for cleaning, disinfecting and/or sterilizing (2019-09-17),
12. 7951832 - Pyrazole derivatives as kinase inhibitors (2011-05-31),

Title: The Innovative Journey of Surya Kanta De in San Diego, CA

Introduction

Surya Kanta De, an accomplished inventor based in San Diego, California, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 11 patents, he has become a pivotal figure in the development of novel therapeutic compounds aimed at treating critical health conditions.

Latest Patents

Among his latest innovations are the dual acting FKBP12 and FKBP52 inhibitors. These patents describe novel compounds in the form of pharmaceutically acceptable salts and compositions. The primary utility of these inventions lies in treating Parkinson's disease, highlighting their importance in addressing a condition that affects millions worldwide.

Career Highlights

Throughout his career, Surya Kanta De has worked with notable companies such as Collidion, Inc. and Plex Pharmaceuticals, Inc. His expertise in pharmaceutical innovation has been influential in advancing drug development processes within these organizations.

Collaborations

Surya has collaborated with talented individuals in his field, including his coworkers Sridhar Govinda Prasad and Hojabr Alimi. Their teamwork has fostered an environment of creativity and innovation, leading to breakthroughs in pharmaceutical research.

Conclusion

With a robust portfolio of patents and a history of collaboration with esteemed colleagues and companies, Surya Kanta De continues to pave the way for innovative treatments in pharmaceuticals. His dedication to improving health outcomes through novel inventions showcases the critical role of inventors in our society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…